RT Journal Article
SR Electronic
T1 Systematic review of the association between ABO blood type and COVID-19 incidence and mortality
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.20.21255816
DO 10.1101/2021.04.20.21255816
A1 Yuqing Bai
A1 Zhou Yan
A1 Eleanor J Murray
YR 2021
UL http://medrxiv.org/content/early/2021/04/23/2021.04.20.21255816.abstract
AB A large proportion of COVID-19 research has been focused on identifying markers of high-risk individuals. However, this research often fails to consider basic epidemiologic concepts to prevent bias in the design, selection, and analysis of observational data. One suspected marker of risk that has been repeatedly assessed is ABO blood type. Given the ease of measuring this biomarker, it is an appealing target for identifying high-risk individuals. However, this same ease of measurement makes associational research on ABO blood type and COVID prone to a range of common epidemiologic errors. We conducted a systematic review of studies assessing correlations between ABO blood type and COVID incidence, hospitalization, and mortality to determine the quality of evidence these studies provide and whether the overall evidence suggests ABO blood type could provide a useful indicator of COVID risk. We conclude that most existing studies are low quality and suffer from major methodological flaws. The few higher-quality studies which do exist find no association between ABO blood type and COVID outcomes. We conclude that there is no evidence to support the use of ABO blood type as a marker for COVID risk or severity.Key PointsThere is no sufficient evidence to conclude a biological relationship between ABO blood types and COVID-19 infection or severity.Biases of existing research could be avoided by careful study design.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Epidemiologic COVID-19 Response Corps at Boston University School of Public Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not human subjects research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData extraction tables are available upon request.